Department of Neuroscience, IRCCS, Istituto di Ricerche Farmacologiche Mario Negri, 20156, Milan, Italy.
Neurotherapeutics. 2014 Jul;11(3):679-95. doi: 10.1007/s13311-014-0277-y.
Microglia/macrophages (M) are major contributors to postinjury inflammation, but they may also promote brain repair in response to specific environmental signals that drive classic (M1) or alternative (M2) polarization. We investigated the activation and functional changes of M in mice with traumatic brain injuries and receiving intracerebroventricular human bone marrow mesenchymal stromal cells (MSCs) or saline infusion. MSCs upregulated Ym1 and Arginase-1 mRNA (p < 0.001), two M2 markers of protective M polarization, at 3 and 7 d postinjury, and increased the number of Ym1(+) cells at 7 d postinjury (p < 0.05). MSCs reduced the presence of the lysosomal activity marker CD68 on the membrane surface of CD11b-positive M (p < 0.05), indicating reduced phagocytosis. MSC-mediated induction of the M2 phenotype in M was associated with early and persistent recovery of neurological functions evaluated up to 35 days postinjury (p < 0.01) and reparative changes of the lesioned microenvironment. In vitro, MSCs directly counteracted the proinflammatory response of primary murine microglia stimulated by tumor necrosis factor-α + interleukin 17 or by tumor necrosis factor-α + interferon-γ and induced M2 proregenerative traits, as indicated by the downregulation of inducible nitric oxide synthase and upregulation of Ym1 and CD206 mRNA (p < 0.01). In conclusion, we found evidence that MSCs can drive the M transcriptional environment and induce the acquisition of an early, persistent M2-beneficial phenotype both in vivo and in vitro. Increased Ym1 expression together with reduced in vivo phagocytosis suggests M selection by MSCs towards the M2a subpopulation, which is involved in growth stimulation and tissue repair.
小胶质细胞/巨噬细胞(M)是损伤后炎症的主要贡献者,但它们也可能响应特定的环境信号促进大脑修复,这些信号可驱动经典(M1)或替代(M2)极化。我们研究了创伤性脑损伤小鼠在接受脑室内人骨髓间充质基质细胞(MSCs)或生理盐水输注后的 M 的激活和功能变化。MSCs 在损伤后 3 和 7 天上调了 Ym1 和精氨酸酶-1mRNA(p<0.001),这两种 M2 保护性极化的标志物,且在损伤后 7 天增加了 Ym1(+)细胞的数量(p<0.05)。MSCs 减少了 CD11b 阳性 M 细胞膜表面溶酶体活性标志物 CD68 的存在(p<0.05),表明吞噬作用减少。MSC 介导的 M 向 M2 表型的诱导与损伤后 35 天内神经功能的早期和持续恢复有关(p<0.01),以及受损微环境的修复变化。在体外,MSCs 直接抑制由肿瘤坏死因子-α+白细胞介素 17 或肿瘤坏死因子-α+干扰素-γ刺激的原代小鼠小胶质细胞的促炎反应,并诱导 M2 促再生特性,表现为诱导型一氧化氮合酶的下调和 Ym1 和 CD206mRNA 的上调(p<0.01)。总之,我们发现证据表明 MSCs 可以在体内和体外驱动 M 的转录环境,并诱导获得早期、持续的 M2 有益表型。体内吞噬作用减少伴随着 Ym1 表达增加表明 MSCs 对 M2a 亚群的选择,该亚群参与生长刺激和组织修复。